BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9016843)

  • 41. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
    Hunter N; Weston KM; Bowern NA
    Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
    Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
    BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gangliosides improve the outcome of experimental allergic neuritis (EAN).
    Oderfeld-Nowak B; Brosnan C; Cervone A; Oderfeld J; Ledeen RW
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):495-504. PubMed ID: 2130664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord.
    D'Amelio FE; Smith ME; Eng LF
    Glia; 1990; 3(4):229-40. PubMed ID: 2144503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
    Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
    Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig.
    Tabira T; Endoh M
    J Neurol Sci; 1985 Feb; 67(2):201-12. PubMed ID: 2580061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens.
    Chalk JB; McCombe PA; Smith R; Pender MP
    J Neurol Sci; 1994 May; 123(1-2):154-61. PubMed ID: 7520480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro NMR micro imaging of the spinal cord of chronic relapsing EAE rats.
    Lanens D; Van der Linden A; Gerrits PO; 's-Gravenmade EJ
    Magn Reson Imaging; 1994; 12(3):469-75. PubMed ID: 8007777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat.
    Juhler M; Barry DI; Offner H; Konat G; Klinken L; Paulson OB
    Brain Res; 1984 Jun; 302(2):347-55. PubMed ID: 6610460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis.
    Beeton C; Garcia A; Chandy KG
    J Vis Exp; 2007; (5):224. PubMed ID: 18979022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental allergic encephalomyelitis in the Lewis rat. A model of predictable relapse by cyclophosphamide.
    Minagawa H; Takenaka A; Itoyama Y; Mori R
    J Neurol Sci; 1987 Apr; 78(2):225-35. PubMed ID: 3494816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
    Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
    Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of experimental allergic encephalomyelitis by ganglioside GM4.
    Mullin BR; Patrick DH; Poore CM; Smith MT
    Brain Res; 1984 Mar; 296(1):174-6. PubMed ID: 6201236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
    Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
    J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
    Schorlemmer HU; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelin metabolism in vitro in experimental allergic encephalomyelitis.
    Smith ME
    J Neurochem; 1969 Jul; 16(7):1099-104. PubMed ID: 5796866
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis.
    Flanagan EM; Erickson JB; Viveros OH; Chang SY; Reinhard JF
    J Neurochem; 1995 Mar; 64(3):1192-6. PubMed ID: 7861150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
    Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
    Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.